Cargando...
Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review
Fabry disease (OMIM 301500) is an X-linked (Xq22.1) lysosomal storage disorder leading to a progressive multisystem disease with high variability in both genotype and phenotype expression. The pathophysiological origin is found in an enzyme deficiency of the α-galactosidase A (enzyme commission no....
Guardado en:
| Publicado en: | Cardiovasc Diagn Ther |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8102271/ https://ncbi.nlm.nih.gov/pubmed/33968645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt-20-743 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|